Intrinsic Value of S&P & Nasdaq Contact Us

Hillstream BioPharma, Inc. HILS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
26/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — HILS

Hillstream BioPharma, Inc. (HILS) has a market capitalization of $4.17M and trades at $0.24. The 52-week range is 0.1723-2.65.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-1.12.

The stock has a beta of 0.00, operates in the Healthcare sector.

Trading Data
Current Price$0.24
52-Week Range0.1723-2.65
Volume313.2K
Avg Volume (30D)684.78K
Market Cap$4.17M
Beta (1Y)0.00
Company
IPO Date2022-01-12
Employees1
CEORandy D. Milby MBA
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS4327051011
CUSIP432705101
Income (Latest Year)
EBITDA$-20.11M
Operating Income$-20.11M
Net Income$-35.92M
EPS$-1.12
EPS Diluted$-1.12
Shares Outstanding$32.05M
Balance Sheet (Latest Year)
Total Assets$519.15M
Current Assets$17.39M
Cash & ST Investments$17.03M
Total Liabilities$121.22M
Net Debt$-17.03M
Total Equity$397.93M
Valuation Ratios
P/E Ratio-0.2
P/B Ratio0.01
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message